Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34012781/
1 Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan. 2 Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan. 3 Department of...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • Conclusion: “DOC [docetaxel] plus RAM [ramucirumab] could be an optimal therapy for previous treated NSCLC patients with lung and liver metastasis, and furthermore, should be used carefully for Show More
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33843600/
The management of patients with NSCLC requires care from a multidisciplinary team, leading to a lack of a single aggregated data source in real-world settings. The availability of integrated clinical...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • Conclusion: “The management of patients with NSCLC requires care from a multidisciplinary team, leading to a lack of a single aggregated data source in real-world settings. The availability Show More
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34099825/
Recently Food and Drug Administration (FDA)-approved pralsetinib (BLU-667) and selpercatinib (LOXO-292) are RET-selective protein tyrosine kinase inhibitors for treating RET-altered cancers, but whether they have distinct activity was unknown. The...
68-Year-Old Female Diagnosed with Stage 1a NSCLC
A 68-year-old woman is referred for treatment of Stage 1a lung cancer. She is a former smoker and has COPD. Four years ago, a 1 cm lesion in the right upper lobe was discovered. A follow-up PET scan showed no uptake.
She began coughing and has increasing shortness of breath. A new CT scan shows...
Liquid biopsy in non-small cell lung cancer-current status and future outlook-a narrative review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34164273/
Lung cancer ranks first as the cause of cancer-associated deaths gobally. The American Cancer Society estimates for 228,820 new cases and 135,720 deaths from lung cancer in the United States...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • The current literature review covers NSCLC liquid biopsy and the advantages/disadvantages of different approaches. • The authors noted that liquid biopsy is uncommonly used, although its popularity is increasing. Show More